Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)

Figure 3

Algorithm for the screening and follow-up of 1326G. 1326G: young women aged 13–26 years asking for a gynaecologic assessment. HPV testing: Nucleic acid extraction from cervical samples (by NucliSENS® EasyMAG™, bioMérieux bv, France) followed by PCR amplification of a 450-base pair fragment of ORF L1 using the degenerate primer pair ELSI-f and ELSI-r.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us